Electron-Transfer/Higher-Energy Collision Dissociation (EThcD)-Enabled Intact Glycopeptide/Glycoproteome Characterization
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Protein glycosylation, one of the most heterogeneous post-translational modifications, can play a major role in cellular signal transduction and disease progression. Traditional mass spectrometry (MS)-based large-scale glycoprotein sequencing studies heavily rely on identifying enzymatically released glycans and their original peptide backbone separately, as there is no efficient fragmentation method to produce unbiased glycan and peptide product ions simultaneously in a single spectrum, and that can be conveniently applied to high throughput glycoproteome characterization, especially for N-glycopeptides, which can have much more branched glycan side chains than relatively less complex O-linked glycans. In this study, a redefined electron-transfer/higher-energy collision dissociation (EThcD) fragmentation scheme is applied to incorporate both glycan and peptide fragments in one single spectrum, enabling complete information to be gathered and great microheterogeneity details to be revealed. Fetuin was first utilized to prove the applicability with 19 glycopeptides and corresponding five glycosylation sites identified. Subsequent experiments tested its utility for human plasma N-glycoproteins. Large-scale studies explored N-glycoproteomics in rat carotid arteries over the course of restenosis progression to investigate the potential role of glycosylation. The integrated fragmentation scheme provides a powerful tool for the analysis of intact N-glycopeptides and N-glycoproteomics. We also anticipate this approach can be readily applied to large-scale O-glycoproteome characterization. Graphical Abstract ᅟ.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Universal sample preparation method for proteome analysis
Wiśniewski, J. R., Zougman, A., Nagaraj, N., & Mann, M. (2009) · Nature Methods · doi:10.1038/nmeth.1322 · Cited by 8,352
UniProt: the Universal Protein knowledgebase
Apweiler, R. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh131 · Cited by 7,498 · cited 6×
“LRP1 is a key suppressor in preventing atherosclerosis and restenosis [82, 83], and N-linked glycosylation is known to influence its proper folding and, more importantly, its resistance to γ-secretase [84, 85].”
BackgroundInfluentialOn the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database
Apweiler, R. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00165-8 · Cited by 1,855 · cited 1×
“Being one of the most common posttranslational modifications (PTMs), glycosylation is estimated to occur in more than half of all eukaryotic proteins [1], with two major types being N-glycosylation and O-glycosylation [2].”
BackgroundVertebrate protein glycosylation: diversity, synthesis and function
Moremen, K. W., Tiemeyer, M., & Nairn, A. V. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3383 · Cited by 1,677 · cited 1×
“However, N-glycosylated proteins are most often highly complex by presenting a multitude of diverse sugar–amino acid combinations and characterization with MS remains a great analytical challenge due to this heterogeneity [4, 5].”
BackgroundSpiro, R. G. (2002) · Glycobiology · doi:10.1093/glycob/12.4.43r · Cited by 1,409 · cited 2×
“Being one of the most common posttranslational modifications (PTMs), glycosylation is estimated to occur in more than half of all eukaryotic proteins [1], with two major types being N-glycosylation and O-glycosylation [2].”
BackgroundPrecision Mapping of an In Vivo N-Glycoproteome Reveals Rigid Topological and Sequence Constraints
Zielinska, D. F., Gnad, F., Wiśniewski, J. R., & Mann, M. (2010) · Cell · doi:10.1016/j.cell.2010.04.012 · Cited by 902
Role of Glycosylation in Development
Haltiwanger, R. S., & Lowe, J. B. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074043 · Cited by 757
Byonic: Advanced Peptide and Protein Identification Software
Bern, M., Kil, Y. J., & Becker, C. (2012) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi1320s40 · Cited by 659 · cited 3×
“All spectra were analyzed with Byonic (Protein Metrics, San Carlos, CA, USA) [52] with corresponding protein databases [i.”
MethodInfluentialLRP: Role in Vascular Wall Integrity and Protection from Atherosclerosis
Boucher, P., Gotthardt, M., Li, W.-P., Anderson, R. G. W., & Herz, J. (2003) · Science · doi:10.1126/science.1082095 · Cited by 581 · cited 1×
“LRP1 is a key suppressor in preventing atherosclerosis and restenosis [82, 83], and N-linked glycosylation is known to influence its proper folding and, more importantly, its resistance to γ-secretase [84, 85].”
BackgroundHägglund, P., Bunkenborg, J., Elortza, F., Jensen, O. N., & Roepstorff, P. (2004) · Journal of Proteome Research · doi:10.1021/pr034112b · Cited by 460
Human plasma protein N-glycosylation
Clerc, F., Reiding, K. R., Jansen, B. C., Kammeijer, G. S. M., Bondt, A., & Wuhrer, M. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-015-9626-2 · Cited by 450
Liu, T., Qian, W.-J., Gritsenko, M. A., Camp, D. G., Monroe, M. E., Moore, R. J., & Smith, R. D. (2005) · Journal of Proteome Research · doi:10.1021/pr0502065 · Cited by 405
The regulatory roles of small leucine‐rich proteoglycans in extracellular matrix assembly
Chen, S., & Birk, D. E. (2013) · The FEBS Journal · doi:10.1111/febs.12136 · Cited by 378 · cited 1×
“Lumican is an extracellular matrix protein extensively modified by keratan sulfate in cornea [74] but occurs predominantly as a glycoprotein with little or no sulfate in arteries [75– 77].”
BackgroundEnrichment of glycopeptides for glycan structure and attachment site identification
Nilsson, J., Rüetschi, U., Halim, A., Hesse, C., Carlsohn, E., Brinkmalm, G., & Larson, G. (2009) · Nature Methods · doi:10.1038/nmeth.1392 · Cited by 322
High-sensitivity Analytical Approaches for the Structural Characterization of Glycoproteins
Alley, W. R., Mann, B. F., & Novotny, M. V. (2013) · Chemical Reviews · doi:10.1021/cr3003714 · Cited by 310 · cited 1×
“However, due to its heterogeneous nature, fragmenting an intact glycopeptide has always been difficult and yet no single fragmentation technique is able to generate a complete picture in a single MS/MS spectrum [6, 7, 14, 15].”
BackgroundFrese, C. K., Altelaar, A. F. M., van den Toorn, H., Nolting, D., Griep-Raming, J., Heck, A. J. R., & Mohammed, S. (2012) · Analytical Chemistry · doi:10.1021/ac3025366 · Cited by 304 · cited 1×
“combined ETD with HCD and developed a hybrid dissociation method, termed EThcD [40].”
MethodMysling, S., Palmisano, G., Højrup, P., & Thaysen-Andersen, M. (2010) · Analytical Chemistry · doi:10.1021/ac100530w · Cited by 298 · cited 1×
“Analysis of a rather simple mixture of modified and native peptides was performed using an enzymatic digest of fetuin, which is highly glycosylated [56, 57].”
MethodSolid-phase extraction of N-linked glycopeptides
Tian, Y., Zhou, Y., Elliott, S., Aebersold, R., & Zhang, H. (2007) · Nature Protocols · doi:10.1038/nprot.2007.42 · Cited by 286
Zielinska, D. F., Gnad, F., Schropp, K., Wiśniewski, J. R., & Mann, M. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.04.031 · Cited by 276
Sun, S., Shah, P., Eshghi, S. T., Yang, W., Trikannad, N., Yang, S., Chen, L., Aiyetan, P., Höti, N., Zhang, Z., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3403 · Cited by 223
Thaysen-Andersen, M., & Packer, N. H. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.05.002 · Cited by 209 · cited 2×
“Traditional glycoproteomic studies usually opt to enzymatically release glycans from their attached peptides, due to their heterogeneous nature, and thereby not amenable to a single fragmentation method [6, 14, 16].”
BackgroundHogan, J. M., Pitteri, S. J., Chrisman, P. A., & McLuckey, S. A. (2005) · Journal of Proteome Research · doi:10.1021/pr049770q · Cited by 190
Determination of site-specific glycan heterogeneity on glycoproteins
Kolarich, D., Jensen, P. H., Altmann, F., & Packer, N. H. (2012) · Nature Protocols · doi:10.1038/nprot.2012.062 · Cited by 188 · cited 1×
“, amino acid site-specific glycoform and microheterogeneity) [11, 12].”
BackgroundEffective Use of Mass Spectrometry for Glycan and Glycopeptide Structural Analysis
Leymarie, N., & Zaia, J. (2012) · Analytical Chemistry · doi:10.1021/ac3000573 · Cited by 183 · cited 1×
“Peaks resulting from glycosidic bond cleavages dominate spectra generated by collision-induced dissociation (CID) with little knowledge of glycosylation sites and amino acid sequences, whereas c/z-ion series in ETD type of experiments yield the glycosylation site and peptide identity with little information on glycan…”
BackgroundMommen, G. P. M., Frese, C. K., Meiring, H. D., van Gaans-van den Brink, J., de Jong, A. P. J. M., van Els, C. A. C. M., & Heck, A. J. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321458111 · Cited by 183 · cited 1×
“A supplemental energy is applied to all ions formed by ETD to generate more informative spectra [41, 42].”
MethodFrese, C. K., Zhou, H., Taus, T., Altelaar, A. F. M., Mechtler, K., Heck, A. J. R., & Mohammed, S. (2013) · Journal of Proteome Research · doi:10.1021/pr301130k · Cited by 181 · cited 1×
“A supplemental energy is applied to all ions formed by ETD to generate more informative spectra [41, 42].”
MethodThaysen-Andersen, M., Packer, N. H., & Schulz, B. L. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o115.057638 · Cited by 178 · cited 3×
“Traditional glycoproteomic studies usually opt to enzymatically release glycans from their attached peptides, due to their heterogeneous nature, and thereby not amenable to a single fragmentation method [6, 14, 16].”
BackgroundGlycopeptide analysis by mass spectrometry
Dalpathado, D. S., & Desaire, H. (2008) · The Analyst · doi:10.1039/b713816d · Cited by 169 · cited 2×
“Traditional glycoproteomic studies usually opt to enzymatically release glycans from their attached peptides, due to their heterogeneous nature, and thereby not amenable to a single fragmentation method [6, 14, 16].”
BackgroundZhao, P., Viner, R., Teo, C. F., Boons, G.-J., Horn, D., & Wells, L. (2011) · Journal of Proteome Research · doi:10.1021/pr2002726 · Cited by 161
Kaji, H., Yamauchi, Y., Takahashi, N., & Isobe, T. (2006) · Nature Protocols · doi:10.1038/nprot.2006.444 · Cited by 160 · cited 1×
“, amino acid site-specific glycoform and microheterogeneity) [11, 12].”
BackgroundZhao, J., Qiu, W., Simeone, D. M., & Lubman, D. M. (2007) · Journal of Proteome Research · doi:10.1021/pr0604458 · Cited by 160
γ-Secretase Limits the Inflammatory Response Through the Processing of LRP1
Zurhove, K., Nakajima, C., Herz, J., Bock, H. H., & May, P. (2008) · Science Signaling · doi:10.1126/scisignal.1164263 · Cited by 145 · cited 1×
“Previous studies have suggested that hyperglycosylation, particularly N-linked glycosylation, would render LRP1 resistant to γ-secretase [86].”
BackgroundDifferential glycosylation regulates processing of lipoprotein receptors by γ-secretase
May, P., Bock, H. H., Nimpf, J., & Herz, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305858200 · Cited by 142 · cited 1×
“LRP1 is a key suppressor in preventing atherosclerosis and restenosis [82, 83], and N-linked glycosylation is known to influence its proper folding and, more importantly, its resistance to γ-secretase [84, 85].”
BackgroundZhou, W., Yao, N., Yao, G., Deng, C., Zhang, X., & Yang, P. (2008) · Chemical Communications · doi:10.1039/b808800d · Cited by 141 · cited 1×
“Accurate mass matching has also been employed in the studies involving glycoprotein standards; however, its applicability to complex mixtures is questionable due to the existence of thousands of possibilities for one m/z value [31, 32].”
BackgroundHinneburg, H., Stavenhagen, K., Schweiger-Hufnagel, U., Pengelley, S., Jabs, W., Seeberger, P. H., Silva, D. V., Wuhrer, M., & Kolarich, D. (2016) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-015-1308-6 · Cited by 136 · cited 2×
“As a consequence, the authors have only demonstrated the utility with a few protein standards, but have not yet been able to apply to real complex samples [29, 30].”
BackgroundSaba, J., Dutta, S., Hemenway, E., & Viner, R. (2012) · International Journal of Proteomics · doi:10.1155/2012/560391 · Cited by 126 · cited 1×
“Later on, a more targeted approach, the product-triggered method, took advantage of the abundant oxonium ion upon HCD by triggering subsequent ETD events only if certain oxonium ions were recognized in the prior HCD MS/MS [38, 39].”
BackgroundCharacterizing protein glycosylation sites through higher‐energy C‐trap dissociation
Segu, Z. M., & Mechref, Y. S. (2010) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.4485 · Cited by 124
Hägglund, P., Matthiesen, R., Elortza, F., Højrup, P., Roepstorff, P., Jensen, O. N., & Bunkenborg, J. (2007) · Journal of Proteome Research · doi:10.1021/pr0700605 · Cited by 120
Tissue-Specific Glycosylation at the Glycopeptide Level
Medzihradszky, K. F., Kaasik, K., & Chalkley, R. J. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.050393 · Cited by 118 · cited 1×
“, CID/HCD/ETD) has become a popular approach as the consensus exists that CID/HCD primarily produces glycan products, whereas ETD cleaves peptide backbones [31, 35, 43, 53].”
BackgroundMechanisms of post-intervention arterial remodelling
Goel, S. A., Guo, L., Liu, B., & Kent, K. C. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs276 · Cited by 109
Self-citationArterial lumican. Properties of a corneal-type keratan sulfate proteoglycan from bovine aorta.
Funderburgh, J. L., Funderburgh, M. L., Mann, M. M., & Conrad, G. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54296-4 · Cited by 109
Chandler, K. B., Pompach, P., Goldman, R., & Edwards, N. J. (2013) · Journal of Proteome Research · doi:10.1021/pr400196s · Cited by 102
Deeb, S. J., Cox, J., Schmidt‐Supprian, M., & Mann, M. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.033977 · Cited by 100
Wu, S., Pu, T.-H., Viner, R., & Khoo, K. (2014) · Analytical Chemistry · doi:10.1021/ac500945m · Cited by 97 · cited 1×
“However, running sequential scans undoubtedly lowers instrument duty cycle and, therefore, sensitivity and sequence coverage, especially with ETD scans consuming milliseconds [51, 54].”
BackgroundRitchie, M. A., Gill, A. C., Deery, M. J., & Lilley, K. S. (2002) · Journal of the American Society for Mass Spectrometry · doi:10.1016/s1044-0305(02)00421-x · Cited by 92
Chen, W., Smeekens, J. M., & Wu, R. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.036251 · Cited by 90
Parker, B. L., Thaysen-Andersen, M., Fazakerley, D. J., Holliday, M., Packer, N. H., & James, D. E. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.054221 · Cited by 88 · cited 4×
“It enabled both HCD and ETD type of fragments to be collected in a single spectrum, enabling improved instrumental speed by greatly shortening ETD reaction times for each charge state [43], complete product ion generation, consisting of glycan fragments, c/z and b/y ions from peptide backbones and, therefore, intact g…”
BackgroundMethodInfluentialA Strategy for Precise and Large Scale Identification of Core Fucosylated Glycoproteins
Jia, W., Lu, Z., Fu, Y., Wang, H.-P., Wang, L., Chi, H., Yuan, Z., Zheng, Z., Song, L.-N., Han, H., et al. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800504-mcp200 · Cited by 85
Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins
Hoffmann, M., Marx, K., Reichl, U., Wuhrer, M., & Rapp, E. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.053546 · Cited by 82 · cited 1×
“In addition, it often requires tedious sample preparation and complex data processing since a complete picture is divided and distributed among several spectra [31, 55].”
BackgroundHart‐Smith, G., & Raftery, M. J. (2011) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-011-0273-y · Cited by 80
Extended O-GlcNAc on HLA Class-I-Bound Peptides
Marino, F., Bern, M., Mommen, G. P. M., Leney, A. C., van Gaans-van den Brink, J. A. M., Bonvin, A. M. J. J., Becker, C., van Els, C. A. C. M., & Heck, A. J. R. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b06586 · Cited by 79
Carbohydrates on Proteins: Site-Specific Glycosylation Analysis by Mass Spectrometry
Zhu, Z., & Desaire, H. (2015) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-071114-040240 · Cited by 79 · cited 1×
“The ideal way to comprehensively characterize glycopeptides, especially in a large-scale glycoproteomics context, is to preserve the glycan side chain on the peptide and collect glycan and peptide fragmentation information simultaneously [13, 14].”
BackgroundThe small leucine‐rich repeat proteoglycans in tissue repair and atherosclerosis
Hultgårdh‐Nilsson, A., Borén, J., & Chakravarti, S. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12400 · Cited by 76
Windwarder, M., & Altmann, F. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.05.022 · Cited by 72
Expression of Lumican in Thickened Intima and Smooth Muscle Cells in Human Coronary Atherosclerosis
Onda, M., Ishiwata, T., Kawahara, K., Wang, R., Naito, Z., & Sugisaki, Y. (2002) · Experimental and Molecular Pathology · doi:10.1006/exmp.2002.2425 · Cited by 72 · cited 1×
“The accumulation of lumican deposition has long been established as an indicator for cardiovascular diseases such as atherosclerosis, restenosis, and aneurysm [78, 79].”
BackgroundCao, L., Tolić, N., Qu, Y., Meng, D., Zhao, R., Zhang, Q., Moore, R., Zink, E., Lipton, M. S. W., Paša‐Tolić, L., et al. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.01.003 · Cited by 69 · cited 2×
“As a consequence, the authors have only demonstrated the utility with a few protein standards, but have not yet been able to apply to real complex samples [29, 30].”
BackgroundHow to Dig Deeper? Improved Enrichment Methods for Mucin Core-1 Type Glycopeptides
Darula, Z., Sherman, J., & Medzihradszky, K. F. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o111.016774 · Cited by 68
Peterman, S. M., & Mulholland, J. J. (2006) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2005.10.008 · Cited by 64 · cited 1×
“Analysis of a rather simple mixture of modified and native peptides was performed using an enzymatic digest of fetuin, which is highly glycosylated [56, 57].”
MethodLarge-scale characterization of intact N-glycopeptides using an automated glycoproteomic method
Cheng, K., Chen, R., Seebun, D., Ye, M., Figeys, D., & Zou, H. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.08.006 · Cited by 63 · cited 1×
“Additional studies identify N-glycopeptides with HCD using the spectra acquired for intact glycopeptides as well as deglycopeptides to explore the heterogeneity assisted by a custom software platform [33, 34].”
MethodYang, W., Shah, P., Eshghi, S. T., Yang, S., Sun, S., Ao, M., Rubin, A., Jackson, J. B., & Zhang, H. (2014) · Analytical Chemistry · doi:10.1021/ac500876p · Cited by 62 · cited 1×
“Additional studies identify N-glycopeptides with HCD using the spectra acquired for intact glycopeptides as well as deglycopeptides to explore the heterogeneity assisted by a custom software platform [33, 34].”
MethodBET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries
Wang, B., Zhang, M., Takayama, T., Shi, X., Roenneburg, D. A., Kent, K. C., & Guo, L. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.09.045 · Cited by 61 · cited 1×
“following angioplasty features the most active cellular events in the vessel wall, such as cell proliferation, migration, and apoptosis, and d 7 post-procedure is frequently used for marking the peak of vascular smooth muscle cells’ proliferative state [73].”
MethodSelf-citationZhu, Z., Su, X., Clark, D. F., Go, E. P., & Desaire, H. (2013) · Analytical Chemistry · doi:10.1021/ac401814h · Cited by 58
Structure determination ofO-linked glycopeptides by tandem mass spectrometry
Medzihradszky, K. F., Gillece-Castro, B. L., Settineri, C. A., Townsend, R. R., Masiarz, F. R., & Burlingame, A. L. (1990) · Journal of Mass Spectrometry · doi:10.1002/bms.1200191205 · Cited by 54
Vascular proteomics in metabolic and cardiovascular diseases
Lynch, M., Barallobre‐Barreiro, J., Jahangiri, M., & Mayr, M. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12486 · Cited by 53 · cited 2×
“Extracellular matrix (ECM) proteins have long been implicated in the pathogenesis of restenosis, and the fact that more than 90% of ECM proteins are glycosylated makes it more relevant to study carotid artery glycoproteomics [71, 72].”
BackgroundA Calibration Routine for Efficient ETD in Large-Scale Proteomics
Rose, C. M., Rush, M. J. P., Riley, N. M., Merrill, A. E., Kwiecien, N. W., Holden, D. D., Mullen, C., Westphall, M. S., & Coon, J. J. (2015) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-015-1183-1 · Cited by 53 · cited 2×
“ETDwas performed with calibrated charge-dependent reaction time [51] (Supplementary Table S1) supplemented by 15% HCD activation, and ion species was analyzed in the Orbitrap at resolution of 60,000 FWHM (at m/z 200).”
BackgroundMethodYe, H., Boyne, M. T., Buhse, L. F., & Hill, J. (2012) · Analytical Chemistry · doi:10.1021/ac3026465 · Cited by 52 · cited 3×
“In addition, it often requires tedious sample preparation and complex data processing since a complete picture is divided and distributed among several spectra [31, 55].”
BackgroundNicolardi, S., van der Burgt, Y. E. M., Dragan, I., Hensbergen, P. J., & Deelder, A. M. (2013) · Journal of Proteome Research · doi:10.1021/pr400136p · Cited by 52
Muratoglu, S. C., Belgrave, S., Lillis, A. P., Migliorini, M., Robinson, S., Smith, E., Zhang, L., & Strickland, D. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028846 · Cited by 48 · cited 1×
“LRP1 is a key suppressor in preventing atherosclerosis and restenosis [82, 83], and N-linked glycosylation is known to influence its proper folding and, more importantly, its resistance to γ-secretase [84, 85].”
BackgroundZhang, C., Ye, Z., Xue, P., Shu, Q., Zhou, Y., Ji, Y., Fu, Y., Wang, J., & Yang, F. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00098 · Cited by 47 · cited 1×
“, Columbia, MD, USA) following a previously reported procedure with minor modification [50].”
MethodHuang, L.-J., Lin, J.-H., Tsai, J.-H., Chu, Y.-Y., Chen, Y.-W., Chen, S.-L., & Chen, S. (2014) · Journal of Chromatography A · doi:10.1016/j.chroma.2014.10.046 · Cited by 44
Chen, R., Wang, F., Tan, Y., Sun, Z., Song, C., Ye, M., Wang, H., & Zou, H. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.12.015 · Cited by 41
Top‐down tandem mass spectrometry on RN ase A and B using a Qh/FT‐ICR hybrid mass spectrometer
Bourgoin‐Voillard, S., Leymarie, N., & Costello, C. E. (2014) · PROTEOMICS · doi:10.1002/pmic.201300433 · Cited by 39
Li, X., Jiang, J. T., Zhao, X., Wang, J., Han, H., Zhao, Y., Peng, B., Zhong, R., Ying, W., & Qian, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081921 · Cited by 37 · cited 6×
“LRP1 is a key suppressor in preventing atherosclerosis and restenosis [82, 83], and N-linked glycosylation is known to influence its proper folding and, more importantly, its resistance to γ-secretase [84, 85].”
BackgroundInfluentialForte, A., Rinaldi, B., Berrino, L., Rossi, F., Galderisi, U., & Cipollaro, M. (2014) · Clinical Science · doi:10.1042/cs20140131 · Cited by 32 · cited 1×
“While the underlying mechanisms have been studied from multiple perspectives [69, 70], the N-glycoproteomics has not been very well characterized, even though N-glycosylation is critical for correct protein folding, stability, and mediating cell attachment [71].”
BackgroundExploring the glycoproteomics landscape with advanced MS technologies
Lazar, I. M., Deng, J., Ikenishi, F., & Lazar, A. C. (2014) · Electrophoresis · doi:10.1002/elps.201400400 · Cited by 26 · cited 1×
“However, due to its heterogeneous nature, fragmenting an intact glycopeptide has always been difficult and yet no single fragmentation technique is able to generate a complete picture in a single MS/MS spectrum [6, 7, 14, 15].”
BackgroundMcCormick, L. M., Urade, R., Arakaki, Y., Schwartz, A. L., & Bu, G. (2005) · Biochemistry · doi:10.1021/bi047652a · Cited by 21 · cited 1×
“LRP1 is a key suppressor in preventing atherosclerosis and restenosis [82, 83], and N-linked glycosylation is known to influence its proper folding and, more importantly, its resistance to γ-secretase [84, 85].”
BackgroundYu, Q., Shi, X., Greer, T., Lietz, C. B., Kent, K. C., & Li, L. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00641 · Cited by 19
Self-citationJahouh, F., Hou, S., Kováč, P., & Banoub, J. H. (2011) · Journal of Mass Spectrometry · doi:10.1002/jms.1980 · Cited by 16
Gu, G., Wan, F., Xue, Y., Cheng, W., Zheng, H., Zhao, Y., FAN, F., Han, Y., Tong, C., & Yao, C. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3020 · Cited by 16 · cited 1×
“The accumulation of lumican deposition has long been established as an indicator for cardiovascular diseases such as atherosclerosis, restenosis, and aneurysm [78, 79].”
BackgroundGiangrande, C., Auberger, N., Rentier, C., Papini, A. M., Mallet, J., Lavielle, S., & Vinh, J. (2016) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-015-1321-9 · Cited by 8
Demian, W. L. L., Naresh, K., Shiao, T. C., Randell, E. W., Roy, R., & Banoub, J. H. (2014) · Journal of Mass Spectrometry · doi:10.1002/jms.3448 · Cited by 6
Cited by
Mass spectrometry approaches to glycomic and glycoproteomic analyses
Ruhaak, L. R., Xu, G., Li, Q., Goonatilleke, E., & Lebrilla, C. B. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00732 · Cited by 395
Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies
Wu, X., Xu, M., Geng, M., Chen, S., Little, P. J., Xu, S., & Weng, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01439-y · Cited by 272
Ion Activation Methods for Peptides and Proteins
Brodbelt, J. S. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04563 · Cited by 248
Interactive Peptide Spectral Annotator: A Versatile Web-based Tool for Proteomic Applications
Brademan, D. R., Riley, N. M., Kwiecien, N. W., & Coon, J. J. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir118.001209 · Cited by 161
Ion Activation Methods for Peptides and Proteins
Macias, L. A., Santos, I. C., & Brodbelt, J. S. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b04859 · Cited by 107
Metadata
- Authors
- Yu, Q., Wang, B., Chen, Z., Urabe, G., Glover, M. S., Shi, X., Guo, L.-W., Kent, K. C., & Li, L.
- Venue
- Journal of the American Society for Mass Spectrometry
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-07-10
- Volume
- 28
- Issue
- 9
- Pages
- 1751-1764
- ISSN
- 1044-0305 (ISSN-L)
- OpenAlex
- W2736206659
- Cited by
- 202
- References
- 81
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.